Jackie Glascock

Jackie Glascock

Company: CureSMA

Job title: Director, Research Programs

Seminars:

Q&A Panel Discussion: Ethics & Trial Design 2:55 pm

• Enrolment criteria for pre-existing immunity titer and how this shifts from company to company • Forward thinking drug development trial design with the patient in mind • How has COVID-19 affected gene therapy trials? What can be learned from this for future trial design?Read more

day: Day Two

Gene Therapy for Spinal Muscular Atrophy: Patient Perspective on Clinical Trials and Impact 2:35 pm

• Impact of gene therapy on the SMA patient population • What really matters? Existing unmet need. How does the risk/benefit ratio differ from developer to patient? • Informing future gene therapy development and focusing on important metricsRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.